![](/img/cover-not-exists.png)
E02*Anti-EGFR or Bevacizumab in first line treatment of RAS wild type metastatic colorectal neoplasm (RwtMCRC): meta-analysis of randomized clincal trials
Tamburini, E., Rudnas, B., Gianni, L., Drudi, F., Nicoletti, S., Santelmo, C., Ridolfi, C., Pasini, G., Fabbri, P., Papi, M., Tassinari, D.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv340.02
Date:
October, 2015
File:
PDF, 32 KB
english, 2015